We are live on ! Find out more
CPA

Cowen Prime Advisors Portfolio holdings

AUM $290M
1-Year Est. Return 57.8%
This Fund
S&P 500
This Quarter Est. Return
+26.74%
1 Year Est. Return
+57.8%
3 Year Est. Return
+115.57%
5 Year Est. Return
+253.93%
10 Year Est. Return
+968.63%
AUM
$264M
AUM Growth
+$38.8M
Cap. Flow
+$153K
Cap. Flow %
0.06%
Top 10 Hldgs %
56.61%
Holding
183
New
11
Increased
36
Reduced
18
Closed
10

Sector Composition

Rank Sector Weight
1 Technology 32.45%
2 Communication Services 22.95%
3 Healthcare 20.99%
4 Industrials 6.29%
5 Materials 5.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QUOT
1
DELISTED
Quotient Technology Inc
QUOT
$47.3M 17.9%
2,897,074
-413,803
-12% -$5.11M
PDFS icon
2
PDF Solutions
PDFS
$1.89B
$30.5M 11.54%
1,716,328
+153,802
+10% +$3.05M
INOV
3
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
$16.4M 6.21%
570,400
-79,900
-12% -$2.05M
VG
4
DELISTED
Vonage Holdings Corporation
VG
$11.7M 4.43%
990,050
+211,750
+27% +$2.76M
ITI
5
DELISTED
Iteris, Inc.
ITI
$10.2M 3.86%
1,652,750
+65,750
+4% +$420K
FRG
6
DELISTED
Franchise Group, Inc.
FRG
$9.68M 3.66%
268,000
+9,370
+4% +$332K
ASPN icon
7
Aspen Aerogels
ASPN
$409M
$7.92M 3%
389,500
-78,114
-17% -$1.65M
LMNX
8
DELISTED
Luminex Corp
LMNX
$5.78M 2.19%
181,120
+10,250
+6% +$304K
KRNT icon
9
Kornit Digital
KRNT
$718M
$5.15M 1.95%
51,994
+800
+2% +$79.1K
LAB icon
10
Standard BioTools
LAB
$252M
$4.44M 1.68%
+983,000
New +$5.4M
GNMK
11
DELISTED
GenMark Diagnostics, Inc
GNMK
$4.18M 1.58%
174,850
-332,150
-66% -$6.17M
SCOR icon
12
Comscore
SCOR
$78.4M
$4.18M 1.58%
+57,080
New +$4.02M
NEPH icon
13
Nephros
NEPH
$49.4M
$4.14M 1.57%
622,750
+47,673
+8% +$376K
RSSS icon
14
Research Solutions
RSSS
$74.3M
$3.85M 1.45%
1,657,500
+981,500
+145% +$2.31M
DMRC icon
15
Digimarc Corp
DMRC
$135M
$3.84M 1.45%
129,493
+5,675
+5% +$225K
GTYH
16
DELISTED
GTY Technology Holdings, Inc. Common Stock
GTYH
$3.52M 1.33%
+551,450
New +$3.88M
DDD icon
17
3D Systems Corp
DDD
$545M
$3.39M 1.28%
123,650
-12,550
-9% -$415K
BRK.B icon
18
Berkshire Hathaway Class B
BRK.B
$1.08T
$3.36M 1.27%
13,140
+175
+1% +$42.5K
JNJ icon
19
Johnson & Johnson
JNJ
$646B
$3M 1.14%
18,260
-25
-0.1% -$4.04K
KKR icon
20
KKR & Co
KKR
$97.6B
$2.87M 1.09%
58,750
-2,500
-4% -$112K
HLIT icon
21
Harmonic Inc
HLIT
$1.31B
$2.87M 1.08%
365,694
+16,539
+5% +$131K
HTGM
22
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
$2.87M 1.08%
43,669
+6,842
+19% +$519K
GAN
23
DELISTED
GAN Ltd
GAN
$2.75M 1.04%
150,950
-477,850
-76% -$12.1M
TACT icon
24
Transact Technologies
TACT
$53.4M
$2.75M 1.04%
252,567
+5,100
+2% +$52K
AZN icon
25
AstraZeneca
AZN
$252B
$2.66M 1.01%
26,760
+125
+0.5% +$12.6K

Similar funds

Cowen Prime Advisors's Q1 2021 Portfolio in Review

As of Q1 2021, Cowen Prime Advisors held 183 positions worth $264M, up 17% from $226M the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Cowen Prime Advisors's Q1 2021 filing shows 11 new, 36 increased, 18 reduced and 10 closed positions. Its largest new stake was Standard BioTools: 983,000 shares worth $4.44M. The largest sale was GAN Ltd, an estimated $12.1M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 32% a quarter earlier, followed by Communication Services and Healthcare.

  • Cowen Prime Advisors's largest Q1 2021 buy was Standard BioTools: 983,000 shares worth $4.44M.
  • Cowen Prime Advisors added most to PDF Solutions in Q1 2021, an estimated $3.05M increase.
  • Cowen Prime Advisors's biggest Q1 2021 reduction was GAN Ltd, cutting an estimated $12.1M.
  • Cowen Prime Advisors fully exited Magnite in Q1 2021, selling an estimated $415K.
  • Cowen Prime Advisors's ten largest holdings make up 57% of its $264M portfolio in Q1 2021.
  • Cowen Prime Advisors opened 11 new positions and closed 10 in Q1 2021.
  • Cowen Prime Advisors's portfolio value rose 17% quarter-over-quarter to $264M.

Based on Cowen Prime Advisors's 13F filing for Q1 2021, filed 27 Apr 2021.